The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection.
about
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana.Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomicsSkin test responsiveness to four new tuberculins in patients with chronic obstructive airways disease receiving short term high doses of, or long term maintenance treatment with, prednisolone: clinical appearances and histometric studiesInfection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.Mycobacterium.Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans.Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis.Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response.Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infectionA preliminary study of the effect of contact with environmental mycobacteria on the pattern of sensitivity to a range of new tuberculins amongst Ugandan adultsMultiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection.Multiple skin testing in leprosyAnalysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer diseaseBuruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.Buruli ulcer disease: prospects for a vaccine.The effect of desert conditions on the reactivity of Libyan schoolchildren to a range of new tuberculins.Multiple skin testing of Kenyan schoolchildren with a series of new tuberculins.Systemic and local interferon-gamma production following Mycobacterium ulcerans infection.Immune response to infection with Mycobacterium ulcerans.Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease.Epidemiology of Buruli ulcer in Amansie West district, Ghana.Mycobacterium ulcerans infection in Ashanti region, Ghana.Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulceransA longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy
P2860
Q33593952-77E38F2F-9BB8-49F6-AA6F-6FB49FCB7D60Q33745230-7F896A7D-7B5F-4680-A919-C842AD64DE96Q33837464-8BF0C2E8-D931-4243-AF87-24B8A0BAAB46Q34033119-4BB5BA32-2074-45B6-AFE1-7C76615B6F48Q34072948-41D2301C-D7D6-436F-9858-6AC6A92D89D0Q34131228-DB916563-927D-4E6D-AFD4-311A6280DD83Q34174558-BFC2E817-D91A-4EB6-8674-DC7B11F7FA7AQ34429309-EE9325DD-4E46-4CB7-950A-24AFC3E1C01CQ34602038-22D5876E-0201-4B20-AFD1-1A225D3814B2Q35689228-51443802-57F8-4EB0-ADEC-C34AD33D6E4FQ35949741-88E9B5DE-D18F-47A5-8673-87BE7259A1EDQ36250390-C45D82A4-2271-46C2-8F03-C1FCFE58DD3EQ36250897-0E8B819C-6EB7-493D-B3FC-AA1148E41091Q36251610-9AA3BACF-293F-4EAD-A83B-CE264B221A39Q36291527-D14048CE-C5B8-43DC-BFAA-E25A300CE3E7Q37015337-3E4A0D68-3489-41E3-9D28-926B0AD8753EQ37093875-45E85E6D-1ACA-4622-B3BD-3A7A04F42631Q37349850-F3E004ED-0E27-4B25-AA64-9E5E9F537667Q37387041-C9408E3A-8E41-46AF-B5BC-6B779C84907AQ39221268-DE8DEDF5-02D7-4158-83B2-0B9C0BA6C104Q39343675-3B585C4E-6B95-49AE-906C-91D4DF9B8D1EQ39436449-7C2BC938-5B30-4F95-BDF8-FA3466E8386DQ39518871-03881582-4853-4440-9669-E7BD813B1D05Q44738439-F8C2EDA3-EF74-41D5-B6A3-11677538379DQ46854734-650B7067-1836-4DFC-8744-1794BB6D06CDQ46876737-6954611A-2D49-49BA-88B6-9AC4C2E1EE04Q57203196-7A566317-617F-4F8C-97F4-BAB2472D29D8Q58826926-91A75DF2-4870-4D95-A28B-A5984D657E32
P2860
The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
The production and preliminary ...... obacterium ulcerans infection.
@ast
The production and preliminary ...... obacterium ulcerans infection.
@en
type
label
The production and preliminary ...... obacterium ulcerans infection.
@ast
The production and preliminary ...... obacterium ulcerans infection.
@en
prefLabel
The production and preliminary ...... obacterium ulcerans infection.
@ast
The production and preliminary ...... obacterium ulcerans infection.
@en
P2093
P2860
P1476
The production and preliminary ...... obacterium ulcerans infection.
@en
P2093
Gunthorpe WJ
Stanford JL
P2860
P356
10.1017/S0022172400046659
P577
1975-02-01T00:00:00Z